Is your GLP-1 cost containment strategy ready?
GLP-1s for weight loss are already driving record pharmacy spend — and with the White House moving to broaden Medicare coverage, that price tag is about to surge even higher.
Join Virta for a 45-minute educational session to unpack the implications of expanded access and lower costs. Our experts will explore:
- The ripple effects of upcoming price cuts and how oral GLP-1s could reshape the market as soon as Q1 2026
- Smart off-cycle strategies to get ahead of rising demand and cost containment challenges
- How to optimize outcomes by pairing GLP-1 therapy with evidence-based nutrition care
Register now to save your spot or get a copy of the recording.